document.write("
"); document.write("
Marazioti,\ A.*\ ; Papadia,\ K.*\ ; Kannavou,\ M.*\ ; Spella,\ M.*\ ; Basta,\ A.*\ ; de Lastic,\ A.L.*\ ; Rodi,\ M.*\ ; Mouzaki,\ A.*\ ; Samiotaki,\ M.*\ ; Panayotou,\ G.*\ ; Stathopoulos,\ G.T.\ ; Antimisiaris,\ S.G.*
"); document.write("
Cellular vesicles: New insights in engineering methods, interaction with cells and potential for brain targeting.
"); document.write("
J. Pharmacol. Exp. Ther. 370, 772-785 (2019)
"); document.write("
"); document.write("
"); document.write("
Zorzan,\ E.*\ ; Da Ros,\ S.*\ ; Giantin,\ M.*\ ; Zorro Shahidian,\ L.\ ; Guerra,\ G.*\ ; Palumbo,\ M.*\ ; Sissi,\ C.*\ ; Dacasto,\ M.*
"); document.write("
Targeting canine KIT promoter by candidate DNA G-quadruplex ligands.
"); document.write("
J. Pharmacol. Exp. Ther. 367, 461-472 (2018)
"); document.write("
"); document.write("
"); document.write("
Daniel,\ C.*\ ; Sartory,\ N.A.*\ ; Zahn,\ N.*\ ; Radeke,\ H.H.*\ ; Stein,\ J.M.*
"); document.write("
Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
"); document.write("
J. Pharmacol. Exp. Ther. 324, 23-33 (2008)
"); document.write("
"); document.write("
"); document.write("
Tizzano,\ J.P.*\ ; Stribling,\ D.S.*\ ; Perez-Tilve,\ D.*\ ; Strack,\ A.*\ ; Frassetto,\ A.*\ ; Chen,\ R.Z.*\ ; Fong,\ T.M.*\ ; Shearman,\ L.*\ ; Krieter,\ P.A.*\ ; Tschöp,\ M.H.\ ; Skolnick,\ P.*\ ; Basile,\ A.S.*
"); document.write("
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity.
"); document.write("
J. Pharmacol. Exp. Ther. 324, 1111-1126 (2008)
"); document.write("
"); document.write("
"); document.write("
Beck-Speier,\ I.\ ; Dayal,\ N.\ ; Karg,\ E.W.\ ; Maier,\ K.L.\ ; Schumann,\ G.\ ; Semmler,\ M.\ ; Koelsch,\ S.M.*
"); document.write("
Oxymetazoline inhibits proinflammatory reactions: Effect on arachidonic acid-derived metabolites.
"); document.write("
J. Pharmacol. Exp. Ther. 316, 843-851 (2006)
"); document.write("
"); document.write("
"); document.write("
Daniel,\ C.*\ ; Radeke,\ H.H.*\ ; Sartory,\ N.A.*\ ; Zahn,\ N.*\ ; Zuegel,\ U.*\ ; Steinmeyer,\ A.*\ ; Stein,\ J.*
"); document.write("
The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
"); document.write("
J. Pharmacol. Exp. Ther. 319, 622-631 (2006)
"); document.write("
"); document.write("
"); document.write("
Banks,\ W.A.*\ ; Tschöp,\ M.H.\ ; Robinson,\ S.M.*\ ; Heiman,\ M.L.*
"); document.write("
Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure.
"); document.write("
J. Pharmacol. Exp. Ther. 302, 822-827 (2002)
"); document.write("
"); document.write("
"); document.write("
Rozman,\ K.K.\ ; Doull,\ J.*
"); document.write("
The Role of Time as a Quantifiable Variable of Toxicity and the Experimental Conditions When Haber\'s c x t Product Can Be Observed : Implications for Therapeutics.
"); document.write("
J. Pharmacol. Exp. Ther. 296, 663-668 (2001)
"); document.write("
"); document.write("
"); document.write("
Saghir,\ S.A.*\ ; Fried,\ K.*\ ; Rozman,\ K.K.
"); document.write("
Kinetics of monochloroacetic acid in adult male rats after intravenous injection of a subtoxic and a toxic dose.
"); document.write("
J. Pharmacol. Exp. Ther. 296, 617-627 (2001)
"); document.write("
");